These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3904441)

  • 41. Pharmacokinetics and safety of low-dose submicron indomethacin 20 and 40 mg compared with indomethacin 50 mg.
    Olugemo K; Solorio D; Sheridan C; Young CL
    Postgrad Med; 2015 Mar; 127(2):223-31. PubMed ID: 25639879
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Studies on sustained-release dosage forms. II. Pharmacokinetics after rectal administration of indomethacin suppositories in rabbits.
    Kuroda T; Yokoyama T; Umeda T; Matsuzawa A; Kuroda K; Asada S
    Chem Pharm Bull (Tokyo); 1983 Sep; 31(9):3319-25. PubMed ID: 6667541
    [No Abstract]   [Full Text] [Related]  

  • 43. Pharmacokinetics of long acting propranolol. Implications for therapeutic use.
    Nace GS; Wood AJ
    Clin Pharmacokinet; 1987 Jul; 13(1):51-64. PubMed ID: 3304770
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bioequivalence and Safety of Twice-Daily Sustained-Release Paracetamol (Acetaminophen) Compared With 3- and 4-Times-Daily Paracetamol: A Repeat-Dose, Crossover Pharmacokinetic Study in Healthy Volunteers.
    Liu DJ; Collaku A
    Clin Pharmacol Drug Dev; 2018 Jan; 7(1):77-86. PubMed ID: 28815997
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bioequivalence studies in humans of indomethacin capsules marketed in India.
    Chaudhari GN; Tipnis HP; Doshi BS; Kulkarni RD
    Eur J Clin Pharmacol; 1984; 26(2):261-4. PubMed ID: 6723767
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Studies on the bioavailability of sustained-release indomethacin capsules].
    Li D; Yang XY; Wang JP; Wang YM; Shan J; Zhang HL; Bai YZ; Tao XH; Mo SY
    Yao Xue Xue Bao; 1985 May; 20(5):387-91. PubMed ID: 4083026
    [No Abstract]   [Full Text] [Related]  

  • 47. Pharmacokinetic evaluation of indomethacin nanocapsules.
    Andrieu V; Fessi H; Dubrasquet M; Devissaguet JP; Puisieux F; Benita S
    Drug Des Deliv; 1989 Jun; 4(4):295-302. PubMed ID: 2775449
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Retard effect of acemetacin from a commercial preparation--kinetics in humans following single and multiple administration].
    Dell HD; Beckermann B; Doersing M; Fischer W; Kamp R; Weber J; Schierstedt D
    Arzneimittelforschung; 1986 Apr; 36(4):747-52. PubMed ID: 3718599
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of a new once-daily controlled-release sarpogrelate hydrochloride compared with immediate-release formulation and the effect of food.
    Kim TE; Kim JR; Jung JA; Kim MJ; Lee SY; Ko JW; Jung WT; Choi YW; Lee HJ; Kim SH; Huh W
    J Clin Pharm Ther; 2014 Apr; 39(2):192-5. PubMed ID: 24325365
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of food on bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms: Part I.
    Ohmori N; Inotsume N; Matsukura M; Higashi A; Iwaoku R; Tobino Y; Nakano M; Matsuda I
    Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):148-52. PubMed ID: 3699941
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics and pharmacodynamics of drug delivery.
    Robinson DS
    Curr Med Res Opin; 1983; 8 Suppl 2():10-9. PubMed ID: 6851621
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kinetics of indomethacin absorption, elimination, and enterohepatic circulation in man.
    Kwan KC; Breault GO; Umbenhauer ER; McMahon FG; Duggan DE
    J Pharmacokinet Biopharm; 1976 Jun; 4(3):255-80. PubMed ID: 978392
    [No Abstract]   [Full Text] [Related]  

  • 53. Bioavailability and pharmacokinetic profile of a newly-developed twice-a-day sustained-release paracetamol formulation.
    Liu DJ; Collaku A; Youngberg SP
    Int J Clin Pharmacol Ther; 2015 Feb; 53(2):172-81. PubMed ID: 25500485
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of food intake on plasma oxprenolol concentrations following oral administration of conventional and Oros preparations.
    John VA; Smith SE
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):191S-195S. PubMed ID: 4005122
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single-dose pharmacokinetics of Madopar HBS in patients and effect of food and antacid on the absorption of Madopar HBS in volunteers.
    Malcolm SL; Allen JG; Bird H; Quinn NP; Marion MH; Marsden CD; O'Leary CG
    Eur Neurol; 1987; 27 Suppl 1():28-35. PubMed ID: 3428307
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An assessment of the pharmacokinetics of a sustained-release formulation of a tramadol/acetaminophen combination in healthy subjects.
    Im YJ; Jeon JY; Kim EY; Kim Y; Oh DJ; Yoo JS; Shin DH; Chae SW; Kim MG
    Clin Ther; 2015 Feb; 37(2):376-89. PubMed ID: 25618318
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selection of 12-Hour Sustained-Release Acetaminophen (Paracetamol) Formulation Through Comparison of Pharmacokinetic Profiles of 4 Sustained-Release Prototype Formulations and Standard Acetaminophen Formulation: An Open-Label, Randomized, Proof-of-Principle Pharmacokinetic Study.
    Yue Y; Liu DJ
    Clin Pharmacol Drug Dev; 2018 Jan; 7(1):87-94. PubMed ID: 28816033
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative bioavailability: influence of various diets on the bioavailability of indomethacin.
    Wallusch WW; Nowak H; Leopold G; Netter KJ
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):40-4. PubMed ID: 631970
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Steady-state pharmacokinetics and tolerability of orally administered fampridine sustained-release 10-mg tablets in patients with multiple sclerosis: a 2-week, open-label, follow-up study.
    Vollmer T; Blight AR; Henney HR
    Clin Ther; 2009 Oct; 31(10):2215-23. PubMed ID: 19922892
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Pharmacokinetics of a theophylline sustained-release formulation after single and twice daily dosage].
    Fuchs WS; von Nieciecki A; Pabst G; Müller M; Dilger C; Gay S; Laicher A; Stanislaus F
    Arzneimittelforschung; 1998 May; 48(5A):589-92. PubMed ID: 9676350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.